RUTHERFORD, N.J., March 17, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq:CGIX), an emerging leader in DNA-based diagnostics, announced today that effective April 1, 2014, it has appointed Edward J. Sitar, CPA as Chief Financial Officer. Mr. Sitar will be responsible for all Corporate Finance and Accounting activities for Cancer Genetics.
Help employers find you! Check out all the jobs and post your resume.
